Noroxymorphone is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence. an opioid for spinal analgesia. It is grouped under the following drug class(es): Schedule II controlled substances. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include (-)-Noroxymorphone, 7, 8-Dihydro-14-hydroxynormorphinone and 14-Hydroxydihydronormorphinone. It is also listed for alternate use as: API Intermediate. It is listed as a controlled drug substance (Schedule II). Its PubChem CID is 5497189.
(-)-Noroxymorphone
| CAS No | 33522-95-1 |
|---|---|
| Molecular Formula | C16H17NO4 |
| Molecular Weight | 287.31 g/mol |
| Synonyms | (4R,4aS,7aR,12bS)-4a,9-dihydroxy-1,2,3,4,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Noroxymorphone is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence.
The listed CAS number is 33522-95-1.
The listed molecular formula is C16H17NO4.
The listed molecular weight is 287.31 g/mol.
(4R,4aS,7aR,12bS)-4a,9-dihydroxy-1,2,3,4,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one.
The source lists (-)-Noroxymorphone, 7, 8-Dihydro-14-hydroxynormorphinone and 14-Hydroxydihydronormorphinone.